Can a Model Predict Where a Drug Will Bind?
Alex Rives says a model that can simulate where a drug distributes and binds across the body is the beginning of a solution to toxicity.
The step he is describing is the move from ESM Fold 2 to a model that can design a molecule and send it toward the clinic with a much better hit rate. Figuring out how to optimize a drug, how to get it through preclinical work, and how to do the early safety check are problems people could spend an entire career on. A new scientific paradigm simplifies questions that were once hard, and he expects many of those problems to be solved in an emergent way. Accurate representations at the molecular level are what he says will start that rapid progress.
From the transcript
And then so there's this one piece, which is fundamental understanding. And then there's this like theory of someday we're just going to be able to like zero shot things into either the clinic or the clinic with much, much better hit rate. What needs to happen for us to go from ESM Fold 2 to this other piece? Is that feasible? I think that's a great question.
I mean, I would say that I'm really optimistic on that. So I think, you know, on the one hand, you know, these are problems that historically, you know, people could spend kind of an entire career working on. Like, how do you figure out how to effectively optimize a drug? How do you get it, you know, get it through preclinical? How do you do the early safety approach? I think that when you have a new scientific paradigm, questions that were once hard become simplified through the new paradigm.